BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing.
It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa.
Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking.